Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Myoelectric Prosthetic Terminal Device Supply

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 339112
New
Federal
SPS Sterilizer
Solicitation # 36C24526Q0758
Solicitation 36C24526Q0758 is a Firm-Fixed Price purchase order issued by the Department of Veterans Affairs for the procurement, delivery, and installation of five new steam sterilizers for the Sterile Processing Service at the Baltimore VA Medical Center in Maryland. The government is seeking Belimed brand or equal equipment with specific requirements, including a chamber volume of at least 275 L and a tray capacity of at least five trays. The project involves a two-phase installation process to maintain continuous operations, requiring the contractor to handle the de-installation and disposal of existing equipment, site preparation, utility reconnection, and the provision of ICRA plans and barriers. System validation and assembly must be performed by an OEM service-trained representative. The award will be based on a comparative evaluation of technical capability, price, and past performance to determine the most advantageous offer to the government. Mandatory submission requirements include a completed SF1449, a specific line-item pricing worksheet, and manufacturer authorization letters for distributors. All quotes must be submitted as FOB Destination. The contractor is required to maintain specific insurance coverages, including 500,000 dollars per occurrence for general liability and 200,000 dollars per person for automobile liability. The response deadline for this unrestricted solicitation is September 14, 2024.
245-NETWORK Contract Office 5 (36C245)

POSTED

about 20 hours ago

DEADLINE

in 2 days

AI Contract Overview

Show more

The contract involves the supply of a TASKA CX or an equivalent myoelectric hand system designed for upper limb bypass prosthetics. This system features electromyographic (EMG) control for intuitive operation, an IP67 rating ensuring protection against dust and water, a Quick Disconnect wrist for ease of use, and includes all necessary accessories such as cables, chargers, and batteries to ensure full functionality. The procurement aims to provide advanced prosthetic technology for enhanced user experience and reliability. Issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, this subcontract opportunity references NAICS code 339112, which relates to prosthetic and orthotic devices manufacturing. The solicitation was posted on May 21, 2026, with a response deadline set for May 29, 2026. Specific location details and points of contact were not provided, but the contract is accessible via the federal contracting platform SAM.gov.

General Info

Supply of TASKA CX myoelectric prosthetic hand with EMG control, IP67 rating, accessories included.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

339112 - Surgical and Medical Instrument ManufacturingView NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

This scope was carved out of 75F40126SSN133891.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Upper Limb Bypass Prothesis System to include TASKA CX

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of a TASKA CX or equivalent myoelectric hand system for upper limb bypass prosthetics, including EMG control, IP67 rating, Quick Disconnect wrist, and all necessary cables, chargers, and batteries.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS